Skip to content

Goran B. G. Klintmalm, M.D.

NPI 1245260280ActiveIndividual· Transplant Surgery· Dallas, TX

Transplant Surgery (M.D.) in Dallas, Texas, licensed in TX, with an NPI issued in July 2006. Part D covered 15 prescriptions written in 2024, 87% of them generic. Veloxis Pharmaceuticals, Inc. reported $43.90 in payments in 2024, mostly food and beverage.

Overview

NPI1245260280
StatusActive
Entity typeIndividual
CredentialM.D.
Sole proprietorNo
NPI issuedJul 4, 2006
Last updated in NPPESOct 20, 2014

Specialties and licenses

TaxonomyCodeLicenseState
Transplant Surgery Primary204F00000XG7835TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Not in the public enrollment file of Oct 1, 2026

Part D prescriptions in 2024

Prescriptions (claims)15 · 39 30-day fills
Total drug cost$3,641
Generic share87% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2024$43.90 · 1 payment from 1 company

Top paying companies in 2024

CompanyAmountPayments
Veloxis Pharmaceuticals, Inc.$43.901

What the 2024 payments were for

  • Food and Beverage$43.90 · 1 payment

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Transplant Surgery providers in Dallas

All 27 Transplant Surgery providers in Dallas · All Transplant Surgery providers in Texas